Please wait...

Learn

Finding accredited CPD

Methylphenidate and (lis)dexamfetamine toxicity‐related deaths of adults, Australia, 2000–24: analysis of NCIS data

Description

The stimulants methylphenidate, dextroamfetamine, and lisdexamfetamine are prescribed for the treatment of attention deficit hyperactivity disorder (ADHD) in adults. The prescribing of ADHD medications has increased notably since 2000, and, while they are considered to have good safety profiles, the number of poisonings in Australia has also increased. Few reports on fatal poisonings with these drugs in adults have been published.

This MJA Research Letter shares more.

Details

Authors: Shane Darke, Amy Peacock, Johan A Duflou, Michael Farrell and Julia Lappin

Article Type: Research Letter

Provided by

CPD Activity Details

Topic

Substance-related Disorders, Diagnostic Techniques, Procedures and Imaging

CAPE Aspects

Effective Year

Educational Activities (EA) - 0.30

Reviewing Performance (RP) - 0.0

Measuring Outcomes (MO) - 0.0

You have to log in to see the content of this module.